Abstract
Background
Ileal pouch-anal anastomosis (IPAA) is a common surgical treatment for ulcerative colitis. Afferent limb stenosis is an infrequent complication following IPAA, suggesting underlying Crohn’s disease (CD). We hypothesized that CD-related single nucleotide polymorphisms (SNPs) are associated with afferent limb stenosis.
Methods
Afferent limb stenosis and CD control group patients were recruited from a prospective institutional inflammatory bowel disease database and associated biobank. Patient demographics, Montreal classification, and medication use were recorded. Ten SNPs associated with stricturing Crohn’s disease were examined in genomic DNA and compared among afferent limb stenosis, stricturing CD, and non-stricturing CD controls.
Results
Twenty-seven afferent limb stenosis and 162 CD control group patients (108 stricturing, 54 non-stricturing) were identified. Patients were gender and race matched. Afferent limb stenosis and stricturing CD controls were younger at diagnosis (Montreal A1/A2 vs. A3) compared to non-stricturing CD controls (both p < 0.05). The majority of afferent limb stenosis patients were non-smokers compared to CD controls (74% vs. 36%, p < 0.01) and did not use biologic therapies (4% vs. 37%, p < 0.001). The FUT2 G allele was more frequent in afferent limb stenosis and stricturing CD controls compared to non-stricturing CD controls (both p < 0.05). The NOD2 T allele was more frequent in stricturing CD controls compared to afferent limb stenosis and non-stricturing CD controls (both p < 0.05).
Conclusion
Afferent limb stenosis patients are phenotypically similar to stricturing CD controls, but differ with lower smoking rates and lower NOD2 allele frequency. Such differences could contribute to the presentation delay with a stricturing phenotype. Selective SNP assessment may help categorize patients likely to develop afferent limb stenosis.
Similar content being viewed by others
References
Melton GB, Fazio VW, Kiran RP, He J, Lavery IC, Shen B et al. Long-term outcomes with ileal pouch-anal anastomosis and Crohn’s disease: pouch retention and implications of delayed diagnosis. Annals of surgery. 2008;248(4):608-16. doi:https://doi.org/10.1097/SLA.0b013e318187ed64.
Fazio VW, Kiran RP, Remzi FH, Coffey JC, Heneghan HM, Kirat HT et al. Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. Annals of surgery. 2013;257(4):679-85. doi:https://doi.org/10.1097/SLA.0b013e31827d99a2.
Dozois EJ, Pemberton JH, Mathis KL, Lightner AL, Hahnsloser D, Loftus EV, Jr et al. Results at Up to 30 Years After Ileal Pouch–Anal Anastomosis for Chronic Ulcerative Colitis. Inflammatory bowel diseases. 2017;23(5):781-90. doi:https://doi.org/10.1097/mib.0000000000001061.
Hueting WE, Buskens E, van der Tweel I, Gooszen HG, van Laarhoven CJ. Results and complications after ileal pouch anal anastomosis: a meta-analysis of 43 observational studies comprising 9,317 patients. Dig Surg. 2005;22(1-2):69-79. doi:https://doi.org/10.1159/000085356.
Shen B, Fazio VW, Remzi FH, Delaney CP, Achkar J-P, Bennett A et al. Endoscopic Balloon Dilation of Ileal Pouch Strictures. The American Journal Of Gastroenterology. 2004;99:2340. doi:https://doi.org/10.1111/j.1572-0241.2004.40604.x.
Shen B. Crohn’s Disease of the Ileal Pouch: Reality, Diagnosis, and Management. Inflammatory bowel diseases. 2008;15(2):284-94. doi:https://doi.org/10.1002/ibd.20661.
Cleynen I, Boucher G, Jostins L, Schumm LP, Zeissig S, Ahmad T et al. Inherited determinants of Crohn’s disease and ulcerative colitis phenotypes: a genetic association study. Lancet (London, England). 2016;387(10014):156-67. doi:https://doi.org/10.1016/S0140-6736(15)00465-1.
Verstockt B, Cleynen I. Genetic Influences on the Development of Fibrosis in Crohn’s Disease. Frontiers in Medicine. 2016;3(24). doi:https://doi.org/10.3389/fmed.2016.00024.
Netz U, Carter JV, Eichenberger MR, Dryden GW, Pan J, Rai SN et al. Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn’s disease. World Journal of Gastroenterology. 2017;23(27):4958-67. doi:https://doi.org/10.3748/wjg.v23.i27.4958.
Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749-53. doi:https://doi.org/10.1136/gut.2005.082909.
Hughes LE. Clinical classification of perianal Crohn’s disease. Diseases of the colon and rectum. 1992;35(10):928-32.
Cleynen I, Gonzalez JR, Figueroa C, Franke A, McGovern D, Bortlik M et al. Genetic factors conferring an increased susceptibility to develop Crohn’s disease also influence disease phenotype: results from the IBDchip European Project. Gut. 2013;62(11):1556-65. doi:https://doi.org/10.1136/gutjnl-2011-300777.
Holm S. A Simple Sequentially Rejective Multiple Test Procedure. Scandinavian Journal of Statistics. 1979;6(2):65-70.
Westfall PH TR, and Wolfinger RD Multiple Comparisons and Multiple Tests Using SAS. 2nd ed. Cary, NC: SAS Institute Inc.; 2011.
Landy J, Al-Hassi HO, McLaughlin SD, Knight SC, Ciclitira PJ, Nicholls RJ et al. Etiology of pouchitis. Inflammatory bowel diseases. 2012;18(6):1146-55. doi:https://doi.org/10.1002/ibd.21911.
Lakatos PL, Vegh Z, Lovasz BD, David G, Pandur T, Erdelyi Z et al. Is current smoking still an important environmental factor in inflammatory bowel diseases? Results from a population-based incident cohort. Inflammatory bowel diseases. 2013;19(5):1010-7. doi:https://doi.org/10.1097/MIB.0b013e3182802b3e.
Lawrance IC, Murray K, Batman B, Gearry RB, Grafton R, Krishnaprasad K et al. Crohn’s disease and smoking: is it ever too late to quit? Journal of Crohn’s & colitis. 2013;7(12):e665-71. https://doi.org/10.1016/j.crohns.2013.05.007.
Gustavsson A, Magnuson A, Blomberg B, Andersson M, Halfvarson J, Tysk C. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn’s disease. Alimentary pharmacology & therapeutics. 2013;37(4):430-7. doi:https://doi.org/10.1111/apt.12176.
Mahid SS, Minor KS, Soto RE, Hornung CA, Galandiuk S. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clinic proceedings. 2006;81(11):1462-71. doi:https://doi.org/10.4065/81.11.1462.
Creamer MR WT, Babb S, et al. Tobacco Product Use and Cessation Indicators Among Adults — United States, 2018. MMWR Morb Mortal Wkly Rep. 2019;68:1013-9. doi: https://doi.org/10.15585/mmwr.mm6845a2.
McLaughlin SD, Clark SK, Bell AJ, Tekkis PP, Ciclitira PJ, Nicholls RJ. Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Diseases of the colon and rectum. 2009;52(5):879-83. doi:https://doi.org/10.1007/DCR.0b013e3181a4f9fa.
Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. American journal of human genetics. 2002;70(4):845-57. doi:https://doi.org/10.1086/339432.
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411(6837):599-603. doi:https://doi.org/10.1038/35079107.
Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn’s disease. Journal of human genetics. 2002;47(9):469-72. doi:https://doi.org/10.1007/s100380200067.
Forni D, Cleynen I, Ferrante M, Cassinotti A, Cagliani R, Ardizzone S et al. ABO histo-blood group might modulate predisposition to Crohn’s disease and affect disease behavior. Journal of Crohn’s & colitis. 2014;8(6):489-94. doi:https://doi.org/10.1016/j.crohns.2013.10.014.
Makivuokko H, Lahtinen SJ, Wacklin P, Tuovinen E, Tenkanen H, Nikkila J et al. Association between the ABO blood group and the human intestinal microbiota composition. BMC microbiology. 2012;12:94. doi:https://doi.org/10.1186/1471-2180-12-94.
Wu H, Sun L, Lin D-P, Shao X-X, Xia S-L, Lv M. Association of Fucosyltransferase 2 Gene Polymorphisms with Inflammatory Bowel Disease in Patients from Southeast China. Gastroenterol Res Pract. 2017;2017:4148651-. https://doi.org/10.1155/2017/4148651.
Viennois E, Zhao Y, Merlin D. Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine. Inflammatory bowel diseases. 2015;21(10):2467-74. doi:https://doi.org/10.1097/MIB.0000000000000444.
Jaskowski TD, Litwin CM, Hill HR. Analysis of serum antibodies in patients suspected of having inflammatory bowel disease. Clin Vaccine Immunol. 2006;13(6):655-60. doi:https://doi.org/10.1128/CVI.00034-06.
Plevy S, Silverberg MS, Lockton S, Stockfisch T, Croner L, Stachelski J et al. Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn’s disease, and ulcerative colitis patients. Inflammatory bowel diseases. 2013;19(6):1139-48. doi:https://doi.org/10.1097/MIB.0b013e318280b19e.
Funding
This work was supported by the John W. Price and Barbara Thruston Atwood Price Trust and a grant from the Mary K. Oxley Foundation.
Author information
Authors and Affiliations
Contributions
Study concept: SG, SOB, ME. Data acquisition: SOB, JH, KS, CF, JB, MP, MS, SG, ME. Statistical analysis: SOB, KS, JP, SR. Drafting of the manuscript: SOB, JH, KS, CF, ME. Critical review of the manuscript: SOB, JH, KS, CF, JB, MP, MS, SG, ME, JP, SR, SG. Approval of the final draft: SOB, JH, KS, CF, JB, MP, MS, SG, ME, JP, SR, SG.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
O’Brien, S.J., Hallion, J., Scheurlen, K.M. et al. Crohn’s disease–related single nucleotide polymorphisms are associated with ileal pouch afferent limb stenosis. J Gastrointest Surg 25, 2377–2386 (2021). https://doi.org/10.1007/s11605-020-04884-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-020-04884-0